Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced, Persistent, or Recurrent Endometrial Cancer × Everolimus × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 23 Neoplasm Metastasis 10 Carcinoma, Renal Cell 10 Neuroendocrine Tumors 8 Recurrence 6 Endometrial Neoplasms 5 Tuberous Sclerosis 3 Triple Negative Breast Neoplasms 3 Neoplasms 3 Kidney Neoplasms 3 Glioma 3 Glioblastoma 3 Carcinoma, Hepatocellular 3 von Hippel-Lindau Disease 2 Skin Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Meningioma 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Gastro-enteropancreatic neuroendocrine tumor 2 Diffuse Intrinsic Pontine Glioma 2 Brain Neoplasms 2 Adenoma, Islet Cell 2 Waldenstrom Macroglobulinemia 1 Vascular Malformations 1 Uterine Neoplasms 1 Unilateral Breast Neoplasms 1 Thyroid cancer, Hurthle cell 1 Thyroid Neoplasms 1 Thyroid Diseases 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡